Accordingly, we further suspected that our two generated gene sets, RAGs and NAGs, could share common grounds with GPAGs and PPAGs as both gene sets could predict the prognosis of patients with GBM in response to bevacizumab treatment. This evidence concerns the gene EFNA5 and glioblastoma.